Uncategorized

Using PCA’s Dispensing Solution

PCA Pharmaceuticals provides prepackaged medications and manufacturer labeled pharmaceuticals for physician dispensing within the clinic.  PCA also provides medical supplies to clinics. We ship nationwide and specialize in working with student health centers, community health centers and independent medical clinics.

PCA’s dispensing system encompasses labeling and tracking tools to make the medication dispensing process as easy as possible for the clinic.  PCA labeled bottles display all required pharmaceutical information and provide four peel-off labels for use on patient medical records, receipts or insurance documentation.  Our dispensing log enables the clinic to write the patient’s name and medication instructions on a label that is placed on the bottle.  The labels are on a carbon sheet that retains an image of the label so the clinic has a record of all dispenses.

PCA also offers software (RxTracker) that automates the pharmaceutical dispensing process.  RxTracker allows clinics to capture dispensing information electronically and print the prescription label from any office printer.  RxTracker will also track drug inventory and automate reordering.  PCA offers both of these dispensing solutions at no additional charge.

Clinics seeking to learn more about in-office pharmaceutical dispensing are encouraged to visit the PCA website or call us at 800.722.0772. 

Schedule a free claims analysis now.

Let’s Talk now

Healthcare Storm 2025: What Will It Be?

Phillip Berry | Jan 1st, 2025
When it comes to American healthcare, we’ve become really good at highlighting its failings. Watching the flurry of lamentations, frustrations, denigrations, and prognostications, over the last few weeks, would lead any rational person to believe that nothing is working in our healthcare system. And, not only is it “not working,” many people conclude that it … more »

continue reading

New Drugs to Market – October Update

Phillip Berry | Oct 25th, 2024
The Food and Drug Administration (FDA) approved three novel drug therapies in October. One of those therapies,  Hympavzi (marstacimab-hncq), is a medication indicated for the treatment of patients with Hemophilia A and Hemophilia B. Hympavzi utilizes a new pathway to help reduce the risk of bleeding episodes in patients with Hemophilia, a disease that impacts … more »

continue reading

Letter From a Pharmacist – On Pharmacy Closures

Phillip Berry | Oct 25th, 2024
Pharmacists have a time-honored role as an integral contributor to the delivery of health care. From the earliest apothecaries to the retail stores of today, community pharmacists have provided guidance about health, wellness and medication therapy. Their expertise ranges from preventive care to the most advanced medications used in the treatment of complex disease.  Despite … more »

continue reading